Moderna’s new influenza vaccine, based on the same mRNA technology used in its COVID-19 vaccine, showed promising results in a major trial.

In response to an increasing number of animals entering the Denver Animal Shelter, the facility is expanding its adoption ...

ICMR coordinates the phase 3 clinical trial of DengiAll across 20 sites and seeks to recruit 10,355 volunteers aged 18-60.